MitraClip® Registry

NCT02033811 · tracked via the Priya Life Science Germany tracker

Sponsor

Klinik für Kardiologie, Pneumologie und Angiologie

Phase

Observational

Started

2014-01

Last updated

2020-02-07

Condition(s) studied

Mitral Regurgitation

Study summary

Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients.

The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * severe mitral regurgitation * percutaneous mitral valve repair (PMVR) with the MitraClip® system Exclusion Criteria: * \< 18 years * Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure

Primary outcome measure(s)

Major cardiac adverse events — 30 days
increase in the 30-day risk of adverse events among patients receiving PMVR

Trial sites (1)

Facility	City	Region	Status
Heinrich Heine University Div. of Cardiology, Pulmonary Disease and Vasculae Medicine	Düsseldorf	Germany	Recruiting

More Klinik für Kardiologie, Pneumologie und Angiologie trials in Germany

Percutaneous Transluminal Angioplasty Registry Recruiting

Registry of Device Implantation Recruiting

Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation Recruiting

Other trials for the same condition

ATLAS (AltaValve) Pivotal Trial Recruiting

The EMBRACE Registry: European Post-Market Registry for Catheter Based Mitral Valve Replacement Starting soon

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry Recruiting

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial Active, not recruiting

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02033811 on ClinicalTrials.gov ↗ ← All trials in Germany